By admin
The Food and Drug Administration (FDA) on Thursday authorized a third dose of Pfizer-BioNTech’s COVID-19 vaccine for older adults and high-risk individuals. The move comes as the Centers for Disease Control and Prevention (CDC) also updated its guidance to recommend the booster for those groups.